• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在西欧开展成人活体肝移植项目:鹿特丹经验

Developing an Adult Living Donor Liver Transplant Program in Western Europe: The Rotterdam Experience.

作者信息

Chorley Alicia Jane, Polak Wojciech G, Tran Khe C K, Terkivatan Turkan, Kissler Jenny, Doukas Michail, Den Hoed Caroline, Thomeer Maarten G, Dwarkasing Roy, Metselaar Herold, Ijzermans Jan N M, Porte Robert J, Kuipers Ernst Johan, Minnee Robert C, Boehnert Markus

机构信息

Division of HPB and Transplant Surgery, Department of Surgery, Erasmus University Medical Centre, Erasmus MC Transplant Institute, Erasmus University Medical Centre, Rotterdam, Netherlands.

Department of Anaesthesiology, Erasmus University Medical Centre, Rotterdam, Netherlands.

出版信息

Transpl Int. 2025 Jul 10;38:14442. doi: 10.3389/ti.2025.14442. eCollection 2025.

DOI:10.3389/ti.2025.14442
PMID:40709349
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12286882/
Abstract

Liver transplantation (LT) is curative for end stage liver disease. Expanding LT indications with limited deceased donor grafts has created organ shortages. Living donor liver transplant (LDLT) increases available organs. In 2019, we restarted our adult LDLT program. We describe our steps to create a successful LDLT program, and our outcomes. Critical steps of program development included market analysis, creation of protocols based on best care practices and a rigorous education program. Patients and donors were then actively recruited for LDLT. Outcomes were measured as morbidity (≥3 on the Clavien-Dindo grading system) and mortality. Between January 2019 and August 2024, 54 LDLT were performed. 2 (3%) donors experienced grade 3A and 7 (12%) donors experience grade 3B complications. There was no donor mortality. 22 (41%) patients were transplanted for PSC, the average MELD score was 13 (6-32). 35 (65%) patients had Roux-en-Y reconstructions. 25 (46%) complications were experienced in 22 (40%) patients, there were 2 recipient deaths. Patient and graft survival after LDLT was 97% and 97%, respectively. This paper reported the successful establishment of a LDLT program in the Netherlands. Establishing a LDLT program brings its own unique challenges, with careful planning and persistence, these challenges can be overcome.

摘要

肝移植(LT)是终末期肝病的治愈方法。随着可用的脑死亡供体器官有限,肝移植适应证的扩大导致了器官短缺。活体供肝移植(LDLT)增加了可用器官数量。2019年,我们重启了成人LDLT项目。我们描述了创建一个成功的LDLT项目的步骤以及我们的成果。项目开发的关键步骤包括市场分析、基于最佳护理实践制定方案以及严格的教育项目。然后积极招募患者和供体进行LDLT。以发病率(Clavien-Dindo分级系统中≥3级)和死亡率来衡量结果。在2019年1月至2024年8月期间,共进行了54例LDLT。2例(3%)供体发生3A级并发症,7例(12%)供体发生3B级并发症。无供体死亡。22例(41%)患者因原发性硬化性胆管炎接受移植,平均终末期肝病模型(MELD)评分是13分(6 - 32分)。35例(65%)患者进行了Roux-en-Y重建。22例(40%)患者发生了25例(46%)并发症,有2例受者死亡。LDLT术后患者和移植物存活率分别为97%和97%。本文报道了荷兰一个LDLT项目的成功建立。建立一个LDLT项目有其自身独特的挑战,但通过精心规划和坚持不懈,这些挑战是可以克服的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e67/12286882/fa2944833919/ti-38-14442-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e67/12286882/fa2944833919/ti-38-14442-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e67/12286882/fa2944833919/ti-38-14442-g001.jpg

相似文献

1
Developing an Adult Living Donor Liver Transplant Program in Western Europe: The Rotterdam Experience.在西欧开展成人活体肝移植项目:鹿特丹经验
Transpl Int. 2025 Jul 10;38:14442. doi: 10.3389/ti.2025.14442. eCollection 2025.
2
Clinical outcomes after ABO-incompatible liver transplantation: A systematic review and meta-analysis.ABO 不相容肝移植后的临床结局:系统评价和荟萃分析。
Transpl Immunol. 2021 Dec;69:101476. doi: 10.1016/j.trim.2021.101476. Epub 2021 Oct 1.
3
Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation: a systematic review and meta-analysis.成人活体供肝肝移植和尸体供肝肝移植的手术结果:一项系统评价和荟萃分析。
Liver Transpl. 2014 Apr;20(4):425-36. doi: 10.1002/lt.23836.
4
The Rochester Protocol for living donor liver transplantation of unresectable colorectal liver metastasis: A 5-year report on selection, approval, and outcomes.罗切斯特不可切除结直肠癌肝转移活体供肝肝移植方案:关于选择、批准及结果的5年报告
Am J Transplant. 2025 Apr;25(4):780-792. doi: 10.1016/j.ajt.2024.09.027. Epub 2024 Sep 25.
5
Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation.性别作为肾移植后同种异体移植及患者相关预后的预测因素。
Cochrane Database Syst Rev. 2024 Dec 19;12(12):CD014966. doi: 10.1002/14651858.CD014966.pub2.
6
The experiences of adults who are on dialysis and waiting for a renal transplant from a deceased donor: a systematic review.接受透析治疗并等待已故捐赠者肾脏移植的成年人的经历:一项系统综述。
JBI Database System Rev Implement Rep. 2015 Mar 12;13(2):169-211. doi: 10.11124/jbisrir-2015-1973.
7
Does modification of portal pressure and flow enhance recovery of the recipient after living donor liver transplantation? A systematic review of literature and expert panel recommendations.门静脉压力和血流的改变能否提高活体肝移植受者的恢复情况?一项文献系统综述及专家小组建议。
Clin Transplant. 2022 Oct;36(10):e14657. doi: 10.1111/ctr.14657.
8
Pediatric living donor liver transplantation for small infants with biliary atresia using interposition portal vein grafts: A multicenter cohort study.使用门静脉间置移植物对小婴儿胆道闭锁进行小儿活体肝移植:一项多中心队列研究。
Liver Transpl. 2025 Jul 1;31(7):890-896. doi: 10.1097/LVT.0000000000000596. Epub 2025 Mar 13.
9
Normothermic and hypothermic machine perfusion preservation versus static cold storage for deceased donor kidney transplantation.常温及低温机器灌注保存与静态冷藏在尸体供肾移植中的比较。
Cochrane Database Syst Rev. 2024 Jul 9;7(7):CD011671. doi: 10.1002/14651858.CD011671.pub3.
10
Personalized survival benefit estimation from living donor liver transplantation with a novel machine learning method for confounding adjustment.采用一种用于混杂因素调整的新型机器学习方法对活体肝移植的个性化生存获益进行估计。
J Hepatol. 2025 May 28. doi: 10.1016/j.jhep.2025.04.040.

本文引用的文献

1
Survival Benefit of Living-Donor Liver Transplant.活体肝移植的生存获益。
JAMA Surg. 2022 Oct 1;157(10):926-932. doi: 10.1001/jamasurg.2022.3327.
2
Surgical complications after living and deceased donor liver transplant: The NSQIP transplant experience.活体和尸肝移植术后的手术并发症:NSQIP 移植经验。
Clin Transplant. 2022 Jun;36(6):e14610. doi: 10.1111/ctr.14610. Epub 2022 May 4.
3
Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: Experience from the European Liver Transplant Registry.
与脑死亡后捐献相比,活体供肝移植治疗自身免疫性肝病的长期预后:来自欧洲肝脏移植登记处的经验。
Am J Transplant. 2022 Feb;22(2):626-633. doi: 10.1111/ajt.16864. Epub 2021 Oct 21.
4
Can Living Donor Liver Transplantation in the United States Reach Its Potential?美国的活体供肝移植能发挥其潜能吗?
Liver Transpl. 2021 Nov;27(11):1644-1652. doi: 10.1002/lt.26220. Epub 2021 Jul 31.
5
Expanding Donor Selection and Recipient Indications for Living Donor Liver Transplantation.扩大活体肝移植供者选择和受者适应证。
Clin Liver Dis. 2021 Feb;25(1):121-135. doi: 10.1016/j.cld.2020.08.011. Epub 2020 Oct 7.
6
Biliary reconstruction and complications in living donor liver transplantation.胆道重建和活体肝移植中的并发症。
Int J Surg. 2020 Oct;82S:138-144. doi: 10.1016/j.ijsu.2020.04.069. Epub 2020 May 5.
7
Living Donor Liver Transplantation: Technical Innovations.活体供肝肝移植:技术创新。
Gastroenterol Clin North Am. 2018 Jun;47(2):253-265. doi: 10.1016/j.gtc.2018.01.001.
8
The International Liver Transplantation Society Living Donor Liver Transplant Recipient Guideline.国际肝移植学会活体肝移植受者指南
Transplantation. 2017 May;101(5):938-944. doi: 10.1097/TP.0000000000001571.
9
The donor advocacy team: a risk management program for living organ, tissue, and cell transplant donors.供体宣传团队:一项针对活体器官、组织和细胞移植供体的风险管理计划。
Surg Today. 2017 Aug;47(8):980-985. doi: 10.1007/s00595-017-1468-z. Epub 2017 Feb 15.
10
Donor safety in living donor liver donation: An Italian multicenter survey.活体肝移植中供体的安全性:一项意大利多中心调查。
Liver Transpl. 2017 Feb;23(2):184-193. doi: 10.1002/lt.24651. Epub 2016 Dec 30.